Pulmonx Corp Quarterly Income Tax Expense (Benefit) in USD from Q3 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pulmonx Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2019 to Q3 2024.
- Pulmonx Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $192K, a 225% increase year-over-year.
- Pulmonx Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $710K, a 24.8% increase year-over-year.
- Pulmonx Corp annual Income Tax Expense (Benefit) for 2023 was $571K, a 61.8% increase from 2022.
- Pulmonx Corp annual Income Tax Expense (Benefit) for 2022 was $353K, a 2.92% increase from 2021.
- Pulmonx Corp annual Income Tax Expense (Benefit) for 2021 was $343K, a 61% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)